SCHEMBL4895614

SCHEMBL4895614

CCc1ccc(S(=O)(=O)N(CC)c2csc(-c3ccc(F)cc3F)n2)cc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
EIF4E P06730 5/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
ALOX15 P16050 1/20 0.38
MAPT P10636 2/20 0.37
KDM4E B2RXH2 2/20 0.37
KMT2A Q03164 4/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MCL1 Q07820 1/20 0.35
TAS2R14 Q9NYV8 1/20 0.34
MEN1 O00255 2/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
USP2 O75604 1/20 0.33
DHFR P00374 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906525 0.91 LMNA (0.47) LMNAEIF4EALDH1A1HPGDHSD17B10
SCHEMBL4911850 0.90 ALDH1A1 (0.39) LMNAALDH1A1HPGDMAPTKDM4E
SCHEMBL4898009 0.89 LMNA (0.46) LMNAEIF4EALDH1A1HPGDHSD17B10
SCHEMBL4906663 0.86 LMNA (0.41) LMNAEIF4EALDH1A1HPGDHSD17B10
SCHEMBL4909123 0.83 MAPT (0.39) LMNAALDH1A1HPGDMAPTKDM4E
SCHEMBL4903011 0.82 ALDH1A1 (0.44) LMNAEIF4EALDH1A1HPGDHSD17B10
SCHEMBL4905858 0.79 LMNA (0.40) LMNAALDH1A1HPGDHSD17B10ALOX15
SCHEMBL4899849 0.79 LMNA (0.46) LMNAEIF4EALDH1A1HPGDHSD17B10
SCHEMBL4900527 0.79 MAPT (0.41) LMNAALDH1A1HPGDHSD17B10ALOX15
SCHEMBL4904959 0.78 MAPT (0.39) LMNAEIF4EALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885EIF4E 3036/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885EIF4E 3036/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.